| Parameter |
Study group n=32 |
Control group n=20 |
P |
| Age [years] |
14.8 (3.7-18.0) |
14.7 (8.1-18.0) |
NS |
| Gender (♂/♀) (n/n, %/%) |
22/11 (66.7% / 33.3%) |
15/5 (75.0% / 25.0%) |
| SBP [mm Hg] |
121.4 ± 10.9 |
122.4 ± 11.7 |
| DBP [mm Hg] |
73.7 ± 10.7 |
70.8 ± 8.19 |
| PP [mm Hg] |
47.7 ± 10.1 |
51.6 ± 9.1 |
| AoSBP [mm Hg] |
102.8 ± 9.7 |
101.0 ± 9.7 |
| AoDBP [mm Hg] |
75.7 ± 10.2 |
72.2 ± 8.4 |
| AoPP [mm Hg] |
27.1 ± 5.3 |
31.5 ± 13.9 |
| AP [mm Hg] |
- 0.4 ± 3.6 |
- 1.8 ± 2.1 |
P=0.08 |
| AIx [%] |
- 1.3 ± 13.3 |
- 6.6 ± 7.3 |
P=0.07 |
| AIx- 75HR [%] |
3.9 ± 15.2 |
- 4.2 ± 7.6 |
P<0.05 |
| SEVR [%] |
139.8 ± 37.6 |
154.0 ± 29.3 |
NS |
SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; PP: Pulse Pressure;
AoSBP: Aortic Systolic Blood Pressure; AoDBP: Aortic Diastolic Blood Pressure;
AoPP: Aortic Pulse Pressure; AP: Augmentation Pressure; Aix: Augmentation
Index; AIx- 75HR: Augmentation Index Corrected for Heart Rate of 75 Beats per
Minute; SEVR: Subendocardial Viability Ratio. |
